Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000671088 | SCV000796032 | likely pathogenic | Nemaline myopathy 2 | 2017-11-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000671088 | SCV000823432 | pathogenic | Nemaline myopathy 2 | 2024-12-16 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr8045Cysfs*137) in the NEB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138). This variant is present in population databases (rs772009599, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with NEB-related conditions. ClinVar contains an entry for this variant (Variation ID: 555293). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003465508 | SCV004200093 | likely pathogenic | Arthrogryposis multiplex congenita 6 | 2024-02-29 | criteria provided, single submitter | clinical testing |